Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial (Q44446438)
Jump to navigation
Jump to search
scientific article published in November 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial |
scientific article published in November 2011 |
Statements
1 reference
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial (English)
1 reference
Lars Wallentin
1 reference
John Eikelboom
1 reference
Hans-Christoph Diener
1 reference
Salim Yusuf
1 reference
Jonas Oldgren
1 reference
Michael D Ezekowitz
1 reference
Paul A Reilly
1 reference
Marco Alings
1 reference
Harald Darius
1 reference
Sean Yang
1 reference
Gabriel Kamensky
1 reference
Stuart J Connolly
1 reference
RE-LY Investigators
1 reference
1 November 2011
1 reference
1 reference
155
1 reference
10
1 reference
660-7, W204
1 reference
Identifiers
1 reference
1 reference